Already a member? Sign in
Category: Prescription Drugs
Most Popular Types: Flexeril, Amrix, APO-Cyclobenzaprine (Show all)
Cyclobenzaprine is a centrally-acting skeletal muscle relaxant used in the treatment of muscle spasm associated with acute painful musculoskeletal conditions.
| Purpose | # of patients |
# of patients with evaluations
Efficacy
|
Major | Moderate | Slight | None | Can’t tell |
|---|---|---|---|---|---|---|---|
| Muscle spasms | 730 | 205 |
|
|
|
|
|
| Fibromyalgia | 642 | 168 |
|
|
|
|
|
| Pain | 307 | 64 |
|
|
|
|
|
| Sleep problems | 164 | 57 |
|
|
|
|
|
| Stiffness/Spasticity | 145 | 36 |
|
|
|
|
|
| Back pain | 111 | 35 |
|
|
|
|
See all 1786 patients currently taking Cyclobenzaprine
Mouse over the table for more information
Commonly reported side effects, conditions, and hospitalizations associated with Cyclobenzaprine
| Drowsiness | 83 | |
|---|---|---|
| Dry mouth (xerostomia) | 47 | |
| Hangover effect | 32 | |
| Poor Concentration | 24 | |
| Sleepiness | 19 | |
| Constipation | 17 | |
| See all 84 reported side effects ▼ | ||
Frequently reported dosages based on patients currently taking Cyclobenzaprine. See all 67 dosages ►
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
| Did not seem to work | 180 | ||
| Other | 105 | ||
| Doctor's advice | 94 | ||
| Side effects too severe | 82 | ||
| Course of treatment ended | 63 | ||
| Expense | 16 | ||
| Change in health plan coverage | 10 | ||
| Personal research | 7 | ||
| Not indicated | 5 |
Adherence
Taking treatment as prescribed
Adherence of Cyclobenzaprine
Always |
284 | 58% |
|
|---|---|---|---|
Usually |
129 | 26% |
|
Sometimes |
69 | 14% |
|
Never |
9 | 2% |
|
Burden
Difficulty being on treatment
Burden of Cyclobenzaprine
Very |
13 | 3% |
|
|---|---|---|---|
Somewhat |
36 | 7% |
|
A little |
73 | 15% |
|
Not at all |
369 | 75% |
|
Cost
Paid out of pocket
Cost of Cyclobenzaprine
$200+ |
3 | 1% |
|
|---|---|---|---|
$100-199 |
2 | 1% |
|
$50-99 |
4 | 1% |
|
$25-49 |
26 | 7% |
|
< $25 |
314 | 90% |
|
See more information, including instructions, precautions, side effects, and interactions.
Report created on May 25, 2012.